(1 - 7 von 7
)
Eli Lilly and : Lilly Oncology to Present Robust Data across Its...
www.marketscreener.com
INDIANAPOLIS, Sept. 23, PRNewswire/ -- Eli Lilly and Company today announced data from a number of studies across the company's oncology product...
PosterSessionOnline
www.postersessiononline.es
Federico Longo Muñoz, Recibido P, Quimioterapia adyuvante basada en la respuesta inicial a quimiorradioterapia preoperatoria en pacientes con cáncer ...
History of Changes for Study: NCT
clinicaltrials.gov
Principal Investigator: Dr. Federico Longo Munoz. Hospital Universitario Doce de Octubre [Recruiting] Madrid, Spain, Contact: Study Coordinator +
sortiert nach Relevanz / Datum